Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
18,903,143
-
Share change
-
-2,837,107
-
Total reported value
-
$108,310,000
-
Price per share
-
$5.73
-
Number of holders
-
35
-
Value change
-
-$16,467,400
-
Number of buys
-
13
-
Number of sells
-
20
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2017
As of 31 Mar 2017,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,903,143 shares.
The largest 10 holders included
SAIF Advisors Ltd, MORGAN STANLEY, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, Eqis Capital Management, Inc., GLG Partners LP, Invesco Ltd., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and MILLENNIUM MANAGEMENT LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.